| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 6,000 | 6,150 | 23:01 |
| Stück | Geld | Kurs | Brief | Stück |
|---|---|---|---|---|
| 35,000 | 6 | |||
| 33,000 | 33 | |||
| 22,200 | 30 | |||
| 16,000 | 500 | |||
| 15,000 | 15 | |||
| 7,800 | 400 | |||
| 6,150 | 626 | |||
Quelle: [URL] https://aktienkurs-orderbuch.finanznachrichten.de/88q.htm [/URL] | ||||
| 626 | 6,000 | |||
| 191 | 5,100 | |||
| 1.061 | 0,001 | |||
| Summe Aktien im Kauf | Verhältnis | Summe Aktien im Verkauf | ||
| 1.878 | 0,857 | 1.610 | ||
| Uhrzeit | Aktienkurs | Stück |
|---|---|---|
Keine Umsätze verfügbar. | ||
| Tagesumsatz Xetra | - | 0 |
Angaben in grüner Schrift zeigen, dass der Aktienkurs im Vergleich zum vorherigen Kurs gestiegen ist. Angaben in roter Schrift zeigen gefallene Börsenkurse.
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 16.06. | 4basebio Plc - Notice of Investor Presentation | 272 | PR Newswire | 4basebio Plc - Notice of Investor Presentation
PR Newswire
LONDON, United Kingdom, June 16
4basebio... ► Artikel lesen | |
| 15.06. | IN BRIEF: 4basebio appoints Jeff Coller to Strategic Advisory Board | 1 | Alliance News | ||
| 15.06. | 4basebio appoints Dr Jeff Coller to advisory board | 2 | Sharecast | ||
| 15.06. | 4basebio Appoints Dr. Jeff Coller to Strategic Advisory Board | 139 | GlobeNewswire (Europe) | Dr. Coller,a Bloomberg Distinguished Professor of RNA Biology and Therapeutics, brings deep expertise to accelerate synthetic DNA and mRNA manufacturingDr. Coller's laboratory team has made seminal... ► Artikel lesen | |
| 4BASEBIO Aktie jetzt für 0€ handeln | |||||
| 15.06. | 4basebio Plc - 4basebio Appoints Dr. Jeff Coller to Strategic Advisory Board | 297 | PR Newswire | 4basebio Plc - 4basebio Appoints Dr. Jeff Coller to Strategic Advisory Board
PR Newswire
LONDON, United Kingdom, June 15
4basebio... ► Artikel lesen |
| Zeit | Aktuelle Nachrichten | Medien | ||
|---|---|---|---|---|
| 18:33 | VALBIOTIS SA: Valbiotis announces the success of its capital increase of EUR10.2M | Dow Jones News | DJ VALBIOTIS SA: Valbiotis announces the success of its capital increase of EUR10.2M
VALBIOTIS SA
VALBIOTIS SA: Valbiotis announces the success of its capital increase of EUR10.2M
26-Jun-2026... ► Artikel lesen | |
| 15:06 | Vifor International AG (CSL Vifor): CHMP recommends revoking marketing authorisation for TAVNEOS (avacopan) in the European Union | PR Newswire | Recommendation follows an Article 20 non-pharmacovigilance procedure Patients currently on TAVNEOS treatment should consult their treating physician ST. GALLEN, Switzerland, June 26, 2026... ► Artikel lesen | |
| 15:48 | CSL Vifor: CHMP Recommends Revocation Of EU Marketing Authorisation For TAVNEO | AFX News | THOUSAND OAKS (dpa-AFX) - Vifor Fresenius Medical Care Renal Pharma and CSL (CSL.AX) announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has recommended... ► Artikel lesen | |
| 17:03 | EQS-News: Darwin AG informiert über die Ergebnisse der ordentlichen Hauptversammlung 2026 | EQS Group (DE) | EQS-News: Darwin AG
/ Schlagwort(e): Hauptversammlung
Darwin AG informiert über die Ergebnisse der ordentlichen Hauptversammlung 2026
26.06.2026 / 17:00 CET/CEST
Für... ► Artikel lesen | |
| 14:06 | Replimune Group, Inc.: Replimune Announces FDA Acceptance of RP1 Biologics License Application Resubmission for Advanced Melanoma | GlobeNewswire (Europe) | WOBURN, Mass., June 26, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical-stage biotechnology company pioneering the development of novel oncolytic immunotherapies, announced... ► Artikel lesen |